![]()
|
|
||||||||
J. Biol. Chem., Vol. 255, Issue 2, 419-427, Jan, 1980
JJ Gorman and JE Folk
The action of human plasma factor XIIIa (thrombin-activated blood
coagulation factor XIII) and guinea pig liver transglutaminase on purified
caseins, fibrin, the derivatized gamma chain of fibrin, and a number of
synthetic glutamine peptides, and peptide derivatives is reported. There
are wide variations in the properties of the individual proteins and
peptides as substrates for amine incorporation by the two
transglutaminases. beta-Casein and several of its derivatives are excellent
substrates for factor XIIIa. However, beta-casein is a relatively poor
substrate for the liver enzyme. The primary site of amine incorporation by
factor XIIIa in beta-casein was identified as glutamine 167. This was
accomplished by labeling with fluorescent amine followed by proteolytic
digestion and identification of labeled peptides. An 11-residue peptide and
a 15-residue peptide, each containing 1 glutamine residue and each modeled
after the primary site of amine incorporation in beta-casein, were
prepared. A 13-residue peptide modeled after the primary crosslinking site
in fibrin gamma chain was also prepared. Each of these polypeptides proved
to be an efficient substrate for factor XIIIa and displayed significantly
better substrate properties than a number of small glutamine peptide
derivatives that are good substrates for liver transglutaminase.
Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII)
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Jager, E. Nir, and S. Weiss Site-specific labeling of proteins for single-molecule FRET by combining chemical and enzymatic modification Protein Sci., March 1, 2006; 15(3): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Iismaa, S. Holman, M. A. Wouters, L. Lorand, R. M. Graham, and A. Husain Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases PNAS, October 28, 2003; 100(22): 12636 - 12641. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Lin, C.-W. Luo, and Y.-H. Chen Localization of the Transglutaminase Cross-linking Site in SVS III, a Novel Glycoprotein Secreted from Mouse Seminal Vesicle J. Biol. Chem., January 25, 2002; 277(5): 3632 - 3639. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Lee, J. G. Chi, S. C. Park, and S. I. Chung Transient Expression of Transglutaminase C During Prenatal Development of Human Muscles J. Histochem. Cytochem., November 1, 2000; 48(11): 1565 - 1574. [Abstract] [Full Text] |
||||
![]() |
N. A. Robinson and R. L. Eckert Identification of Transglutaminase-reactive Residues in S100A11 J. Biol. Chem., January 30, 1998; 273(5): 2721 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Corbett, L. Lee, C. L. Wilson, and J. E. Schwarzbauer Covalent Cross-linking of Fibronectin to Fibrin Is Required for Maximal Cell Adhesion to a Fibronectin-Fibrin Matrix J. Biol. Chem., October 3, 1997; 272(40): 24999 - 25005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hettasch, K. A. Peoples, and C. S. Greenberg Analysis of Factor XIII Substrate Specificity Using Recombinant Human Factor XIII and Tissue Transglutaminase Chimeras J. Biol. Chem., October 3, 1997; 272(40): 25149 - 25156. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Lee, C. S. Lee, W.-C. Tae, K. W. Jackson, V. J. Christiansen, and P. A. McKee Cross-linking of Wild-type and Mutant alpha 2-Antiplasmins to Fibrin by Activated Factor XIII and by a Tissue Transglutaminase J. Biol. Chem., November 22, 2000; 275(48): 37382 - 37389. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |